Metabolite information |
|
| HMDB ID | HMDB0011740 |
| Synonyms |
3-O-Hexopyranosylhex-2-ulose3-O-a-D-Glucopyranosyl-D-fructose3-O-alpha-D-Glucopyranosyl-D-fructose3-O-α-D-glucopyranosyl-D-fructoseD-(+)-TuranoseD-Turanosea-D-GLCP-(1->3)-D-frualpha-D-GLCP-(1->3)-D-fruα-D-GLCP-(1->3)-D-fru |
| Chemical formula | C12H22O11 |
| IUPAC name | (3S,4R,5R)-1,4,5,6-tetrahydroxy-3-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexan-2-one |
| CAS registry number | 547-25-1 |
| Monoisotopic molecular weight | 342.116211546 |
Chemical taxonomy |
|
| Super class | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Sub class | Fatty acyl glycosides |
Biological properties |
|
| Pathways (Pathway Details in HMDB) |
|
| Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
| Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
| Ro?-Mazurczyk et al. 2017 | Poland | serum | diagnosis | adenocarcinoma, squamous cell carcinoma | I, II, III | 31 | 17, 14 | 52-72 | – | healthy | 92 | 52, 40 | 52-73 | – |
| Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
| Ro?-Mazurczyk et al. 2017 | GC | – | – | TOF | In-source fragmentation |
| Reference | Data processing software | Database search |
| Ro?-Mazurczyk et al. 2017 | Leco ChromaTOF-GC | Replib, Mainlib and Fiehn libraries |
| Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
| Ro?-Mazurczyk et al. 2017 | two-sample T test, U Mann-Whitney test, Benjamini-Hochberg approach | 0.20914 ± 0.1477 | 0.17504 ± 0.09622 | 1.19 | 0.09 | 0.40 | – |
| Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
| Ro?-Mazurczyk et al. 2017 | ROC curve | – | – | – | – | – |